Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Shareholders Equity (Quarterly) : -9.553M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -9.553M |
| December 31, 2025 | -13.55M |
| September 30, 2025 | -13.04M |
| June 30, 2025 | -21.35M |
| March 31, 2025 | 88.39M |
| December 31, 2024 | 82.06M |
| September 30, 2024 | 98.09M |
| June 30, 2024 | 131.98M |
| March 31, 2024 | 134.41M |
| December 31, 2023 | 43.60M |
| September 30, 2023 | 46.75M |
| June 30, 2023 | 46.50M |
| March 31, 2023 | 66.13M |
| December 31, 2022 | 66.90M |
| September 30, 2022 | 70.32M |
| June 30, 2022 | 72.62M |
| March 31, 2022 | 161.24M |
| December 31, 2021 | 165.62M |
| September 30, 2021 | 166.98M |
| June 30, 2021 | 174.66M |
| March 31, 2021 | 162.32M |
| December 31, 2020 | 161.94M |
| September 30, 2020 | 164.23M |
| June 30, 2020 | 166.27M |
| March 31, 2020 | 170.22M |
| Date | Value |
|---|---|
| December 31, 2019 | 171.28M |
| September 30, 2019 | 172.18M |
| June 30, 2019 | 173.10M |
| March 31, 2019 | 143.97M |
| December 31, 2018 | 148.72M |
| September 30, 2018 | 153.59M |
| June 30, 2018 | 155.90M |
| March 31, 2018 | 143.36M |
| December 31, 2017 | 1.853M |
| September 30, 2017 | 2.760M |
| June 30, 2017 | 1.533M |
| March 31, 2017 | -1.606M |
| December 31, 2016 | -1.284M |
| September 30, 2016 | -0.798M |
| June 30, 2016 | -0.6374M |
| March 31, 2016 | -0.0634M |
| December 31, 2015 | 0.4418M |
| September 30, 2015 | 0.717M |
| June 30, 2015 | |
| March 31, 2015 | 2.672M |
| December 31, 2014 | 3.482M |
| September 30, 2014 | -2.381M |
| June 30, 2014 | -2.631M |
| March 31, 2014 | |
| December 31, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.860M |
| Total Liabilities (Quarterly) | 19.41M |
| Debt to Equity Ratio | -0.1477 |
| Current Ratio | 0.1936 |
| Net Debt Paydown Yield | 6.80% |